Launch week offerEnds in00h00m00s

annual Promonthly Pro

Markus Morkel

Has grant

Research Group Leader

Charité - Universitätsmedizin Berlin

Germany

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in Germany Professors in Cell Biology Cell Biology professors in Germany

Recent Grants

Grant: Close

Investigation of ERK Activity as a Proxy for Targeted Therapy Resistance in KRAS-mutant Colorectal Cancer

Open Date: 2020-01-01

Close Date:

Grant: Close

Systematic analyses of CTNNB1-, BRAF-, KRAS- and PIK3CA-induced oncogenic activities in the intestinal epithelium

Open Date: 2015-01-01

Close Date:

Articles (9)

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Collaborators (7)

Dan Cacsire Castillo-Tong

Group leader / Prof. Dr

Medical University of Vienna

AUSTRIA

View details

Jörg Rahnenführer

Technische Universität Dortmund

GERMANY

View details

Livius Penter

Max-Eder Research Group leader

Charité - Universitätsmedizin Berlin

GERMANY

View details

Susanne Krug

Charité - Universitätsmedizin Berlin

GERMANY

View details

Jarno Drost

Principal Investigator

Oncode Institute

NETHERLANDS

View details

Benedikt Obermayer

Berlin Institute of Health at Charité - Universitätsmedizin Berlin

GERMANY

View details

Dieter Beule

Berlin Institute of Health at Charité - Universitätsmedizin Berlin

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Markus Morkel

Research Interests

Make your next move.

Explore related searches

Recent Grants

Articles (9)

Pooled single-cell screen in colorectal cancer defines transcriptional modules linked to oncogenes

Reporter-based screening identifies RAS-RAF mutations as drivers of resistance to active-state RAS inhibitors in colorectal cancer

Diagnosing recipient- vs. donor-derived posttransplant myelodysplastic neoplasm via targeted single-cell mutational profiling.

Elimination of CDX2 restricts intestinal hybrid differentiation signatures in stem cell-derived hepatocyte-like cells

GPA33 expression in colorectal cancer can be induced by WNT inhibition and targeted by cellular therapy

AHRR and SFRP2 in primary versus recurrent high-grade serous ovarian carcinoma and their prognostic implication

High‐confidence calling of normal epithelial cells allows identification of a novel stem‐like cell state in the colorectal cancer microenvironment

Robust detection of clinically relevant features in single-cell RNA profiles of patient-matched fresh and formalin-fixed paraffin-embedded (FFPE) lung cancer tissue

Oncogenic signaling is coupled to colorectal cancer cell differentiation state

Collaborators (7)

Dan Cacsire Castillo-Tong

Jörg Rahnenführer

Livius Penter

Susanne Krug

Jarno Drost

Benedikt Obermayer

Dieter Beule

Make your next move.